Memorial Sloan Kettering Cancer Center · 9 hours ago
Postdoctoral Fellow – AI & Computational Hematology
Memorial Sloan Kettering Cancer Center (MSK) is dedicated to ending cancer for life through innovative research and personalized care. They are seeking highly motivated postdoctoral fellows to develop and validate AI systems for medical image analysis and clinical data integration, with opportunities for independent research and publication.
EducationHealth CareHospitalLife ScienceTraining
Responsibilities
Develop and validate AI systems for medical image analysis, LLM-based tooling, and multimodal clinical data integration
Lead projects, publish in high-impact journals, and contribute to clinically deployed and commercial-grade systems
Collaborate closely with MSKCC clinical services and maintain active collaborations with external partners at UC San Francisco and UC Berkeley Statistics
Qualification
Required
PhD, MD/PhD, or equivalent doctoral degree in computer science, biomedical engineering, computational biology, medical physics, or a related field
Prior experience in deep learning, computer vision, or medical imaging. Experience with pathology images strongly preferred
Demonstrated ability to conduct independent research and publish in peer-reviewed venues
Demonstrated ability to leverage AI-assisted programming to rapidly prototype, iterate, and deploy beta versions of research tools
Company
Memorial Sloan Kettering Cancer Center
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life.
H1B Sponsorship
Memorial Sloan Kettering Cancer Center has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (260)
2024 (293)
2023 (287)
2022 (314)
2021 (275)
2020 (266)
Funding
Current Stage
Late StageTotal Funding
$102.31MKey Investors
Hyundai Hope On WheelsMassMutual FoundationNational Cancer Institute
2024-08-28Grant· $0.1M
2023-07-12Grant· $0.01M
2022-09-27Grant· $0.2M
Leadership Team
Recent News
Genetic Engineering News
2026-01-20
2026-01-16
2026-01-15
Company data provided by crunchbase